Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zostavax Vaccination of Stem Cell Donors to Prevent Herpes Zoster in Recipients
NCT01573182Phase 2Completed
- Sponsor
- University of Sydney
- Start
- Apr 2012
- Primary completion
- May 2018
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of zoster vaccine, live in herpes zoster (HZ), sponsored by University of Sydney. Started Apr 2012; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT01573182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01573182.